The Food and Drug Administration (FDA) has identified another drug that could have especially dangerous side effects in children – Provigil, approved to treat sleep disorders. Experts want a stronger warning placed on the drug’s label expressly stating that it is not approved for use in pediatric patients.
The Consumer Product Safety Commission wants you to know something that may change the way you think about decorating for the holiday season – 10,000 people go to the emergency room every year with injuries due to holiday decorations. Whether picking out a Christmas tree or lighting your Menorah for Chanukah, the holiday season has many potential dangers that can be prevented by remembering that safety comes first at all times.
The Food and Drug Administration (FDA) has recommended that extra label precautions be added to two different prescription flu medications for children. Tamiflu and Relenza may be linked to potential neurological problems that have contributed to the deaths of 25 children worldwide.
A new study has discovered a health risk that could affect 25 percent of American women – birth control pills may lead to heart disease. Researchers found that birth control pills may be connected to an increased risk of plaque forming inside the arteries, which could raise the risk of heart disease in the 100 million women worldwide who are “on the pill.”
The label of the diabetes drug, Avandia, has been strengthened even further to include a warning about the risk of heart attack. The Food and Drug Administration (FDA) has added to its already strong warning for Avandia, which carries a label that was updated to include risk of heart failure earlier this year.
Vioxx, the dangerous painkiller that was pulled from the market after research showed it was linked to heart attack and stroke, could lead to the second largest drug lawsuit settlement in history. The manufacturer, Merck, has offered to create a fund totaling $4.85 billion to pay off as many as 47,000 plaintiff groups involved in cases that allege serious damages due to Vioxx use.
The Food and Drug Administration (FDA) has reached an agreement with the makers of Trasylol, a prominent blood loss drug used in heart bypass surgery, to suspend sales in the United States. The FDA has requested that Bayer Pharmaceuticals halt marketing of Trasylol after a recent study found that the drug had an increased risk of death compared to other medication.